US cancer death rates continue to decline, national report finds

January 8, 2013 in Cancer

A report from the nation's leading cancer organizations shows rates of death in the United States from all cancers for men and women continued to decline between 2000 and 2009. The findings come from the latest Annual Report to the Nation on the Status of Cancer.

The report also finds that during the same period the overall cancer incidence rate for men decreased and remained stable for women. Among children ages 14 years or younger, the report shows cancer incidence rates increased 0.6 percent per each year from 1992 through 2009. However, considerable progress has been seen for many types of , resulting in overall declines in death rates for cancer among children since at least 1975.

Edward J. Benz, Jr., MD, president of Dana-Farber Cancer Institute in Boston, called the news encouraging, but says the overall number of cancer incidences and mortality rates are not falling nearly enough.

"Cancer rates are declining, continuing a trend that started some years ago. People are surviving more and we are getting better at preventing some cancers," said Benz. "But we're not taking advantage of all the ways to detect cancers at an early stage when they can be the most curable."

The report is co-authored by researchers from the , the North American Association of Central Cancer Registries, the National Cancer Institute, and the . It will be published in the Journal of the (print issue 3, volume 105) and will appear on the journal's website on Monday, Jan. 7.

In a special feature section, the authors also showed an increase in the incidence rate of (HPV)-associated cancers, including head and neck cancers. The authors highlighted the important role of vaccination in the prevention of both cervical and non-cervical HPV-associated cancers.

"We are seeing a large number of patients with HPV-associated and these patients are relatively young, are typically non-smokers and quite often have children," said Robert I. Haddad, MD, chief of Dana-Farber's head and neck oncology program. "HPV is a cause of many cancers, so it is really important to support endeavors to vaccinate."

Benz noted that the good news is that utilizing these prevention strategies, such as vaccinations for HPV, can have a big impact on incidence and death rates.

"Many of the things that are still a problem in these statistics can be changed," said Benz.

Journal reference: Journal of the National Cancer Institute search and more info website

Provided by Dana-Farber Cancer Institute search and more info website

4.3 /5 (3 votes)  

Filter


Move the slider to adjust rank threshold, so that you can hide some of the comments.


Display comments: newest first

nanotech_republika_pl
Jan 08, 2013

Rank: not rated yet
My guess on causes for cancer death rates to fall in US: the falling rate of smoking (direct and second-hand). But on the other side there is a decline in food quality people eat, maybe especially kids. And when it comes to kids, increasing the rate of the computer play to the outdoor play.

It is all about toxins influencing epigenetic makeup of the cells in the human body and genetic damage.
Rank 4.3 /5 (3 votes)
Relevant PhysicsForums posts

More news stories

Key find for early bladder cancer treatment

Aggressive forms of bladder cancer involve the protein PODXL – a discovery that could hold the key to improved treatment, according to researchers at Lund University, Uppsala University and KTH in Sweden.

Cancer created 2 hours ago | popularity 5 / 5 (1) | comments 0

Cold plasma successful against brain cancer cells

For the first time, physicists from the Max Planck Institute for Extraterrestrial Physics (MPE), biologists and physicians demonstrated the synergistic effect of cold atmospheric plasma - a partly ionized ...

Cancer created 2 hours ago | popularity 5 / 5 (1) | comments 0 | with audio podcast

Non-Hodgkin lymphoma survival doubles since early 1970s

More than half of patients diagnosed with Non-Hodgkin Lymphoma (NHL) are now surviving the disease thanks to improved diagnosis and treatment, according to a new report1 from Cancer Research UK.

Cancer created 3 hours ago | popularity 5 / 5 (1) | comments 0

Researchers find possible 'master switch' in deadly brain cancer

(Medical Xpress)—Researchers at the University of Virginia School of Medicine have identified a promising target for treating glioblastoma, one that appears to avoid many of the obstacles that typically frustrate efforts ...

Cancer created 3 hours ago | popularity 3.5 / 5 (2) | comments 0 | with audio podcast

American cancer society celebrates 100 years of progress

(HealthDay)—The American Cancer Society, which is celebrating on Wednesday a century of fighting a disease once viewed as a death sentence, is making a pledge to put itself out of business.

Cancer created 17 hours ago | popularity not rated yet | comments 0


Researchers suggest boosting body's natural flu killers

A known difficulty in fighting influenza (flu) is the ability of the flu viruses to mutate and thus evade various medications that were previously found to be effective. Researchers at the Hebrew University of Jerusalem have ...

Anxious men fare worse during job interviews, study finds

Nervous about that upcoming job interview? You might want to take steps to reduce your jitters, especially if you are a man.

Second-generation TAVI device—Lotus Valve—shows good performance in REPRISE II

22 May 2013, Paris, France: The Lotus Valve, a second-generation transcatheter aortic valve implantation (TAVI) device, was successfully implanted in all of the first 60 patients in results from REPRISE II reported at EuroPCR ...

Major human drug trial underway for Alzheimer's

A potentially ground-breaking human drug trial is currently underway, which aims to discover whether blood pressure medication can slow or halt the progression of Alzheimer's Disease (AD). This is the latest ...

Pay attention: How we focus and concentrate

Scientists at Newcastle University have shed new light on how the brain tunes in to relevant information.

New discovery in fight against deadly meningococcal disease

Professor Michael Jennings, Deputy Director of the Institute for Glycomics at Griffith University, was part of an international team that discovered the previously unknown pathway of how the bacterium colonizes people.